Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 1576648)

1.
2.
3.

Vestibulo-ocular reflex in migraine patients: the effect of sodium valproate.

Gordon CR, Kuritzky A, Doweck I, Spitzer O, Shupak A, Hering R.

Headache. 1993 Mar;33(3):129-32.

PMID:
8486508
4.

Divalproex sodium in migraine prophylaxis: a dose-controlled study.

Klapper J.

Cephalalgia. 1997 Apr;17(2):103-8. Erratum in: Cephalalgia 1997 Nov;17(7):798.

PMID:
9137847
6.

Migraine prophylaxis with divalproex.

Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL.

Arch Neurol. 1995 Mar;52(3):281-6.

PMID:
7872882
7.

Prophylactic sodium valproate therapy in patients with drug-resistant migraine.

Ghose K, Niven B.

Methods Find Exp Clin Pharmacol. 1998 May;20(4):353-9.

PMID:
9658386
8.

Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.

Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M.

Headache. 2008 Jul;48(7):1012-25.

PMID:
18705027
9.

Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.

Mitsikostas DD, Polychronidis I.

Funct Neurol. 1997 Sep-Oct;12(5):267-76.

PMID:
9439944
10.

The prophylactic effect of valproate on glyceryltrinitrate induced migraine.

Tvedskov JF, Thomsen LL, Iversen HK, Gibson A, Wiliams P, Olesen J.

Cephalalgia. 2004 Jul;24(7):576-85.

PMID:
15196300
11.

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH; Investigators.

Cephalalgia. 2002 Sep;22(7):523-32.

PMID:
12230594
12.

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K; Depakote ER Migraine Study Group.

Neurology. 2002 Jun 11;58(11):1652-9.

PMID:
12058094
13.

Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.

Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA; Protocol 125 study group.

Headache. 2004 Jun;44(6):581-6.

PMID:
15186302
14.

Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study.

Millán-Guerrero RO, Isais-Millán R, Barreto-Vizcaíno S, Rivera-Castaño L, Garcia-Solorzano A, López-Blanca C, Membrila-Maldonado M, Muñoz-Solis R.

Eur J Neurol. 2007 Oct;14(10):1079-84.

PMID:
17880560
15.
16.

Sodium valproate prophylaxis in childhood migraine.

Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S.

Headache. 2002 Sep;42(8):819-22.

PMID:
12390647
17.

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.

Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP; Study Group.

Headache. 2009 Feb;49(2):216-26. doi: 10.1111/j.1526-4610.2008.01326.x.

PMID:
19222595
18.

Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.

Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P.

Headache. 2000 Oct;40(9):720-3.

PMID:
11091289
19.

Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.

Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F.

Eur J Paediatr Neurol. 2005;9(5):333-8. Epub 2005 Aug 24.

PMID:
16120482
20.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group.

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk